Koesten, Hirschmann & Crabtree »

Myriad Genetics shares owned by Koesten, Hirschmann & Crabtree

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Koesten, Hirschmann & Crabtree from 13F filings

Historical chart of Koesten, Hirschmann & Crabtree investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Koesten, Hirschmann & Crabtree consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Koesten, Hirschmann & Crabtree

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2k 55 21.33

More positions owned by Koesten, Hirschmann & Crabtree

Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Vanguard Index Fds Large Cap Etf (VV)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Apple (AAPL)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Koesten, Hirschmann & Crabtree

Top funds holding Myriad Genetics

BlackRock
Vanguard Group
Wellington Management Company
Camber Capital Management
Millennium Management
State Street Corporation
Earnest Partners
Glenview Captal Management
Dimensional Fund Advisors
Bank of America Corporation
Artisan Partners Limited Partnership
Sei Investments
Geode Capital Management
Disciplined Growth Investors
Citadel Advisors

View all funds holding Myriad Genetics